The CENTAURI™ System

The Centauri System

The CENTAURI System has CE certification.

The CENTAURI System in an Investigational device in the United States. Limited by Federal (or United States) law to investigational use.

CardioFocus is the exclusive distributor of the CENTAURI System.

Contact a Sales Representative


The CENTAURI System for use in conventional intracardiac ablation procedures uses Pulsed Electric Field (PEF) technology that is optimized for cardiac tissue. It connects to marketed mapping systems and focal ablation catheters, enabling PEF to be delivered through the tools electrophysiologists already have in their labs.

As compared to thermal (hot or cold) technologies, PEF ablation may have significant safety advantages including reductions in:

  • Esophageal injury
  • Phrenic nerve injury
  • Pulmonary vein stenosis
  • Stroke induced by microbubble formation from ablation
Centauri System Machine

The six-pillar approach to PEF therapy for the use in conventional intracardiac ablation procedures gives electrophysiologists a next generation ablation tool designed for the highest level of safety and efficacy.

A custom waveform, for use in conventional intracardiac ablation procedures, balances full-thickness tissue ablation while limiting the effects on extracardiac structures.

The CENTAURI Constellation energy delivery scheme gives physicians control, allowing one of three doses to be used for varying tissue thickness.

The WAVE1 waveform was designed to significantly reduce microbubbles which may embolize to the brain. CENTAURI has been designed using WAVE1 energy for safe and effective delivery of PEF. Our goal is a safe and effective delivery of PEF with zero bubbles.

CENTAURI uses monopolar PEF delivery for lesion control.

Tissue impedance is patient specific and impacts lesion formation during PEF delivery. CENTAURI monitors this between every delivery and optimizes dosing parameters to ensure consistent predictable transmural lesions.

The CENTAURI current control algorithm ensures a consistent current output from the catheter in all patients ensuring predictable lesion size.

Clinical Studies

Two clinical studies have been conducted to characterize the safety and efficacy of CENTAURI.

Overall, 89% PV isolation 3 months using CENTAURI System with three compatible commercially available cardiac ablation catheters

Anić A et al. Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results. Europace. 2023 Jun 2;25(6):euad147.
Download PDF

Instructions For Use

Contact a Sales Representative